Table of Content

1 Study Coverage
1.1 Targeted Antitumor Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Targeted Antitumor Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injection
1.2.3 Tablet
1.2.4 Others
1.3 Market by Application
1.3.1 Global Targeted Antitumor Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Lung Cancer
1.3.3 Lymphoma
1.3.4 Breast Cancer
1.3.5 Leukaemia
1.3.6 Prostate Cancer
1.3.7 Multiple Bone Marrow Cancer
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Targeted Antitumor Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Targeted Antitumor Drugs Revenue by Region
2.2.1 Global Targeted Antitumor Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Targeted Antitumor Drugs Revenue by Region (2018-2024)
2.2.3 Global Targeted Antitumor Drugs Revenue by Region (2024-2029)
2.2.4 Global Targeted Antitumor Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Targeted Antitumor Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Targeted Antitumor Drugs Sales by Region
2.4.1 Global Targeted Antitumor Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Targeted Antitumor Drugs Sales by Region (2018-2024)
2.4.3 Global Targeted Antitumor Drugs Sales by Region (2024-2029)
2.4.4 Global Targeted Antitumor Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Targeted Antitumor Drugs Sales by Manufacturers
3.1.1 Global Targeted Antitumor Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Targeted Antitumor Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Targeted Antitumor Drugs in 2022
3.2 Global Targeted Antitumor Drugs Revenue by Manufacturers
3.2.1 Global Targeted Antitumor Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Targeted Antitumor Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Targeted Antitumor Drugs Revenue in 2022
3.3 Global Key Players of Targeted Antitumor Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Targeted Antitumor Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Targeted Antitumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Targeted Antitumor Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Targeted Antitumor Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Targeted Antitumor Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Targeted Antitumor Drugs Sales by Type
4.1.1 Global Targeted Antitumor Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Targeted Antitumor Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Targeted Antitumor Drugs Sales Market Share by Type (2018-2029)
4.2 Global Targeted Antitumor Drugs Revenue by Type
4.2.1 Global Targeted Antitumor Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Targeted Antitumor Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Targeted Antitumor Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Targeted Antitumor Drugs Price by Type
4.3.1 Global Targeted Antitumor Drugs Price by Type (2018-2024)
4.3.2 Global Targeted Antitumor Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Targeted Antitumor Drugs Sales by Application
5.1.1 Global Targeted Antitumor Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Targeted Antitumor Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Targeted Antitumor Drugs Sales Market Share by Application (2018-2029)
5.2 Global Targeted Antitumor Drugs Revenue by Application
5.2.1 Global Targeted Antitumor Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Targeted Antitumor Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Targeted Antitumor Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Targeted Antitumor Drugs Price by Application
5.3.1 Global Targeted Antitumor Drugs Price by Application (2018-2024)
5.3.2 Global Targeted Antitumor Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Targeted Antitumor Drugs Market Size by Type
6.1.1 US & Canada Targeted Antitumor Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Targeted Antitumor Drugs Revenue by Type (2018-2029)
6.2 US & Canada Targeted Antitumor Drugs Market Size by Application
6.2.1 US & Canada Targeted Antitumor Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Targeted Antitumor Drugs Revenue by Application (2018-2029)
6.3 US & Canada Targeted Antitumor Drugs Market Size by Country
6.3.1 US & Canada Targeted Antitumor Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Targeted Antitumor Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Targeted Antitumor Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Targeted Antitumor Drugs Market Size by Type
7.1.1 Europe Targeted Antitumor Drugs Sales by Type (2018-2029)
7.1.2 Europe Targeted Antitumor Drugs Revenue by Type (2018-2029)
7.2 Europe Targeted Antitumor Drugs Market Size by Application
7.2.1 Europe Targeted Antitumor Drugs Sales by Application (2018-2029)
7.2.2 Europe Targeted Antitumor Drugs Revenue by Application (2018-2029)
7.3 Europe Targeted Antitumor Drugs Market Size by Country
7.3.1 Europe Targeted Antitumor Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Targeted Antitumor Drugs Sales by Country (2018-2029)
7.3.3 Europe Targeted Antitumor Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Targeted Antitumor Drugs Market Size
8.1.1 China Targeted Antitumor Drugs Sales (2018-2029)
8.1.2 China Targeted Antitumor Drugs Revenue (2018-2029)
8.2 China Targeted Antitumor Drugs Market Size by Application
8.2.1 China Targeted Antitumor Drugs Sales by Application (2018-2029)
8.2.2 China Targeted Antitumor Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Targeted Antitumor Drugs Market Size by Type
9.1.1 Asia Targeted Antitumor Drugs Sales by Type (2018-2029)
9.1.2 Asia Targeted Antitumor Drugs Revenue by Type (2018-2029)
9.2 Asia Targeted Antitumor Drugs Market Size by Application
9.2.1 Asia Targeted Antitumor Drugs Sales by Application (2018-2029)
9.2.2 Asia Targeted Antitumor Drugs Revenue by Application (2018-2029)
9.3 Asia Targeted Antitumor Drugs Sales by Region
9.3.1 Asia Targeted Antitumor Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Targeted Antitumor Drugs Revenue by Region (2018-2029)
9.3.3 Asia Targeted Antitumor Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Targeted Antitumor Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Targeted Antitumor Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Roche Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene Overview
11.2.3 Celgene Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Celgene Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celgene Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Johnson & Johnson Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Lilly
11.5.1 Lilly Company Information
11.5.2 Lilly Overview
11.5.3 Lilly Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Lilly Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lilly Recent Developments
11.6 AstraZeneca plc.
11.6.1 AstraZeneca plc. Company Information
11.6.2 AstraZeneca plc. Overview
11.6.3 AstraZeneca plc. Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 AstraZeneca plc. Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AstraZeneca plc. Recent Developments
11.7 Betta Pharmaceuticals
11.7.1 Betta Pharmaceuticals Company Information
11.7.2 Betta Pharmaceuticals Overview
11.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Betta Pharmaceuticals Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Betta Pharmaceuticals Recent Developments
11.8 Shanghai Henlius Biopharmaceutical
11.8.1 Shanghai Henlius Biopharmaceutical Company Information
11.8.2 Shanghai Henlius Biopharmaceutical Overview
11.8.3 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shanghai Henlius Biopharmaceutical Recent Developments
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Information
11.9.2 Innovent Biologics Overview
11.9.3 Innovent Biologics Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Innovent Biologics Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Innovent Biologics Recent Developments
11.10 Nanjing Shunxin Pharmaceuticals
11.10.1 Nanjing Shunxin Pharmaceuticals Company Information
11.10.2 Nanjing Shunxin Pharmaceuticals Overview
11.10.3 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nanjing Shunxin Pharmaceuticals Recent Developments
11.11 CSPC OUYI Pharmaceutical
11.11.1 CSPC OUYI Pharmaceutical Company Information
11.11.2 CSPC OUYI Pharmaceutical Overview
11.11.3 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CSPC OUYI Pharmaceutical Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Information
11.12.2 Qilu Pharmaceutical Overview
11.12.3 Qilu Pharmaceutical Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Qilu Pharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Shenzhen Salubris Pharmaceuticals
11.13.1 Shenzhen Salubris Pharmaceuticals Company Information
11.13.2 Shenzhen Salubris Pharmaceuticals Overview
11.13.3 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments
11.14 Yaopharma
11.14.1 Yaopharma Company Information
11.14.2 Yaopharma Overview
11.14.3 Yaopharma Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Yaopharma Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Yaopharma Recent Developments
11.15 Lianyungang Runzhong Pharmaceutical
11.15.1 Lianyungang Runzhong Pharmaceutical Company Information
11.15.2 Lianyungang Runzhong Pharmaceutical Overview
11.15.3 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Lianyungang Runzhong Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Targeted Antitumor Drugs Industry Chain Analysis
12.2 Targeted Antitumor Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Targeted Antitumor Drugs Production Mode & Process
12.4 Targeted Antitumor Drugs Sales and Marketing
12.4.1 Targeted Antitumor Drugs Sales Channels
12.4.2 Targeted Antitumor Drugs Distributors
12.5 Targeted Antitumor Drugs Customers
13 Market Dynamics
13.1 Targeted Antitumor Drugs Industry Trends
13.2 Targeted Antitumor Drugs Market Drivers
13.3 Targeted Antitumor Drugs Market Challenges
13.4 Targeted Antitumor Drugs Market Restraints
14 Key Findings in The Global Targeted Antitumor Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Targeted Antitumor Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Tablet
Table 4. Major Manufacturers of Others
Table 5. Global Targeted Antitumor Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Targeted Antitumor Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Targeted Antitumor Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Targeted Antitumor Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Targeted Antitumor Drugs Revenue Market Share by Region (2018-2024)
Table 10. Global Targeted Antitumor Drugs Revenue Market Share by Region (2024-2029)
Table 11. Global Targeted Antitumor Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Targeted Antitumor Drugs Sales by Region (2018-2024) & (K Units)
Table 13. Global Targeted Antitumor Drugs Sales by Region (2024-2029) & (K Units)
Table 14. Global Targeted Antitumor Drugs Sales Market Share by Region (2018-2024)
Table 15. Global Targeted Antitumor Drugs Sales Market Share by Region (2024-2029)
Table 16. Global Targeted Antitumor Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Targeted Antitumor Drugs Sales Share by Manufacturers (2018-2024)
Table 18. Global Targeted Antitumor Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Targeted Antitumor Drugs Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Targeted Antitumor Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Targeted Antitumor Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Targeted Antitumor Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Targeted Antitumor Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Antitumor Drugs as of 2022)
Table 24. Global Key Manufacturers of Targeted Antitumor Drugs, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Targeted Antitumor Drugs, Product Offered and Application
Table 26. Global Key Manufacturers of Targeted Antitumor Drugs, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Targeted Antitumor Drugs Sales by Type (2018-2024) & (K Units)
Table 29. Global Targeted Antitumor Drugs Sales by Type (2024-2029) & (K Units)
Table 30. Global Targeted Antitumor Drugs Sales Share by Type (2018-2024)
Table 31. Global Targeted Antitumor Drugs Sales Share by Type (2024-2029)
Table 32. Global Targeted Antitumor Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Targeted Antitumor Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Targeted Antitumor Drugs Revenue Share by Type (2018-2024)
Table 35. Global Targeted Antitumor Drugs Revenue Share by Type (2024-2029)
Table 36. Targeted Antitumor Drugs Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Targeted Antitumor Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Targeted Antitumor Drugs Sales by Application (2018-2024) & (K Units)
Table 39. Global Targeted Antitumor Drugs Sales by Application (2024-2029) & (K Units)
Table 40. Global Targeted Antitumor Drugs Sales Share by Application (2018-2024)
Table 41. Global Targeted Antitumor Drugs Sales Share by Application (2024-2029)
Table 42. Global Targeted Antitumor Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Targeted Antitumor Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Targeted Antitumor Drugs Revenue Share by Application (2018-2024)
Table 45. Global Targeted Antitumor Drugs Revenue Share by Application (2024-2029)
Table 46. Targeted Antitumor Drugs Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Targeted Antitumor Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Targeted Antitumor Drugs Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Targeted Antitumor Drugs Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Targeted Antitumor Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Targeted Antitumor Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Targeted Antitumor Drugs Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Targeted Antitumor Drugs Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Targeted Antitumor Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Targeted Antitumor Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Targeted Antitumor Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Targeted Antitumor Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Targeted Antitumor Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Targeted Antitumor Drugs Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Targeted Antitumor Drugs Sales by Country (2024-2029) & (K Units)
Table 61. Europe Targeted Antitumor Drugs Sales by Type (2018-2024) & (K Units)
Table 62. Europe Targeted Antitumor Drugs Sales by Type (2024-2029) & (K Units)
Table 63. Europe Targeted Antitumor Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Targeted Antitumor Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Targeted Antitumor Drugs Sales by Application (2018-2024) & (K Units)
Table 66. Europe Targeted Antitumor Drugs Sales by Application (2024-2029) & (K Units)
Table 67. Europe Targeted Antitumor Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Targeted Antitumor Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Targeted Antitumor Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Targeted Antitumor Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Targeted Antitumor Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Targeted Antitumor Drugs Sales by Country (2018-2024) & (K Units)
Table 73. Europe Targeted Antitumor Drugs Sales by Country (2024-2029) & (K Units)
Table 74. China Targeted Antitumor Drugs Sales by Type (2018-2024) & (K Units)
Table 75. China Targeted Antitumor Drugs Sales by Type (2024-2029) & (K Units)
Table 76. China Targeted Antitumor Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Targeted Antitumor Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Targeted Antitumor Drugs Sales by Application (2018-2024) & (K Units)
Table 79. China Targeted Antitumor Drugs Sales by Application (2024-2029) & (K Units)
Table 80. China Targeted Antitumor Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Targeted Antitumor Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Targeted Antitumor Drugs Sales by Type (2018-2024) & (K Units)
Table 83. Asia Targeted Antitumor Drugs Sales by Type (2024-2029) & (K Units)
Table 84. Asia Targeted Antitumor Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Targeted Antitumor Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Targeted Antitumor Drugs Sales by Application (2018-2024) & (K Units)
Table 87. Asia Targeted Antitumor Drugs Sales by Application (2024-2029) & (K Units)
Table 88. Asia Targeted Antitumor Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Targeted Antitumor Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Targeted Antitumor Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Targeted Antitumor Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Targeted Antitumor Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Targeted Antitumor Drugs Sales by Region (2018-2024) & (K Units)
Table 94. Asia Targeted Antitumor Drugs Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales by Country (2024-2029) & (K Units)
Table 108. Roche Company Information
Table 109. Roche Description and Major Businesses
Table 110. Roche Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Roche Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Roche Recent Developments
Table 113. Celgene Company Information
Table 114. Celgene Description and Major Businesses
Table 115. Celgene Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Celgene Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Celgene Recent Developments
Table 118. Novartis Company Information
Table 119. Novartis Description and Major Businesses
Table 120. Novartis Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Novartis Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novartis Recent Developments
Table 123. Johnson & Johnson Company Information
Table 124. Johnson & Johnson Description and Major Businesses
Table 125. Johnson & Johnson Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Johnson & Johnson Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Johnson & Johnson Recent Developments
Table 128. Lilly Company Information
Table 129. Lilly Description and Major Businesses
Table 130. Lilly Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Lilly Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Lilly Recent Developments
Table 133. AstraZeneca plc. Company Information
Table 134. AstraZeneca plc. Description and Major Businesses
Table 135. AstraZeneca plc. Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. AstraZeneca plc. Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. AstraZeneca plc. Recent Developments
Table 138. Betta Pharmaceuticals Company Information
Table 139. Betta Pharmaceuticals Description and Major Businesses
Table 140. Betta Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Betta Pharmaceuticals Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Betta Pharmaceuticals Recent Developments
Table 143. Shanghai Henlius Biopharmaceutical Company Information
Table 144. Shanghai Henlius Biopharmaceutical Description and Major Businesses
Table 145. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Shanghai Henlius Biopharmaceutical Recent Developments
Table 148. Innovent Biologics Company Information
Table 149. Innovent Biologics Description and Major Businesses
Table 150. Innovent Biologics Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Innovent Biologics Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Innovent Biologics Recent Developments
Table 153. Nanjing Shunxin Pharmaceuticals Company Information
Table 154. Nanjing Shunxin Pharmaceuticals Description and Major Businesses
Table 155. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Nanjing Shunxin Pharmaceuticals Recent Developments
Table 158. CSPC OUYI Pharmaceutical Company Information
Table 159. CSPC OUYI Pharmaceutical Description and Major Businesses
Table 160. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. CSPC OUYI Pharmaceutical Recent Developments
Table 163. Qilu Pharmaceutical Company Information
Table 164. Qilu Pharmaceutical Description and Major Businesses
Table 165. Qilu Pharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Qilu Pharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Qilu Pharmaceutical Recent Developments
Table 168. Shenzhen Salubris Pharmaceuticals Company Information
Table 169. Shenzhen Salubris Pharmaceuticals Description and Major Businesses
Table 170. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Shenzhen Salubris Pharmaceuticals Recent Developments
Table 173. Yaopharma Company Information
Table 174. Yaopharma Description and Major Businesses
Table 175. Yaopharma Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Yaopharma Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Yaopharma Recent Developments
Table 178. Lianyungang Runzhong Pharmaceutical Company Information
Table 179. Lianyungang Runzhong Pharmaceutical Description and Major Businesses
Table 180. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Lianyungang Runzhong Pharmaceutical Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Targeted Antitumor Drugs Distributors List
Table 186. Targeted Antitumor Drugs Customers List
Table 187. Targeted Antitumor Drugs Market Trends
Table 188. Targeted Antitumor Drugs Market Drivers
Table 189. Targeted Antitumor Drugs Market Challenges
Table 190. Targeted Antitumor Drugs Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Targeted Antitumor Drugs Product Picture
Figure 2. Global Targeted Antitumor Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Targeted Antitumor Drugs Market Share by Type in 2022 & 2029
Figure 4. Injection Product Picture
Figure 5. Tablet Product Picture
Figure 6. Others Product Picture
Figure 7. Global Targeted Antitumor Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Targeted Antitumor Drugs Market Share by Application in 2022 & 2029
Figure 9. Lung Cancer
Figure 10. Lymphoma
Figure 11. Breast Cancer
Figure 12. Leukaemia
Figure 13. Prostate Cancer
Figure 14. Multiple Bone Marrow Cancer
Figure 15. Others
Figure 16. Targeted Antitumor Drugs Report Years Considered
Figure 17. Global Targeted Antitumor Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Targeted Antitumor Drugs Revenue 2018-2029 (US$ Million)
Figure 19. Global Targeted Antitumor Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Targeted Antitumor Drugs Revenue Market Share by Region (2018-2029)
Figure 21. Global Targeted Antitumor Drugs Sales 2018-2029 ((K Units)
Figure 22. Global Targeted Antitumor Drugs Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Targeted Antitumor Drugs Sales YoY (2018-2029) & (K Units)
Figure 24. US & Canada Targeted Antitumor Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Targeted Antitumor Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. Europe Targeted Antitumor Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Targeted Antitumor Drugs Sales YoY (2018-2029) & (K Units)
Figure 28. China Targeted Antitumor Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Targeted Antitumor Drugs Sales YoY (2018-2029) & (K Units)
Figure 30. Asia (excluding China) Targeted Antitumor Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales YoY (2018-2029) & (K Units)
Figure 32. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Targeted Antitumor Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Targeted Antitumor Drugs in the World: Market Share by Targeted Antitumor Drugs Revenue in 2022
Figure 35. Global Targeted Antitumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Targeted Antitumor Drugs Sales Market Share by Type (2018-2029)
Figure 37. Global Targeted Antitumor Drugs Revenue Market Share by Type (2018-2029)
Figure 38. Global Targeted Antitumor Drugs Sales Market Share by Application (2018-2029)
Figure 39. Global Targeted Antitumor Drugs Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Targeted Antitumor Drugs Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Targeted Antitumor Drugs Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Targeted Antitumor Drugs Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Targeted Antitumor Drugs Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Targeted Antitumor Drugs Revenue Share by Country (2018-2029)
Figure 45. US & Canada Targeted Antitumor Drugs Sales Share by Country (2018-2029)
Figure 46. U.S. Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Targeted Antitumor Drugs Sales Market Share by Type (2018-2029)
Figure 49. Europe Targeted Antitumor Drugs Revenue Market Share by Type (2018-2029)
Figure 50. Europe Targeted Antitumor Drugs Sales Market Share by Application (2018-2029)
Figure 51. Europe Targeted Antitumor Drugs Revenue Market Share by Application (2018-2029)
Figure 52. Europe Targeted Antitumor Drugs Revenue Share by Country (2018-2029)
Figure 53. Europe Targeted Antitumor Drugs Sales Share by Country (2018-2029)
Figure 54. Germany Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. France Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. China Targeted Antitumor Drugs Sales Market Share by Type (2018-2029)
Figure 60. China Targeted Antitumor Drugs Revenue Market Share by Type (2018-2029)
Figure 61. China Targeted Antitumor Drugs Sales Market Share by Application (2018-2029)
Figure 62. China Targeted Antitumor Drugs Revenue Market Share by Application (2018-2029)
Figure 63. Asia Targeted Antitumor Drugs Sales Market Share by Type (2018-2029)
Figure 64. Asia Targeted Antitumor Drugs Revenue Market Share by Type (2018-2029)
Figure 65. Asia Targeted Antitumor Drugs Sales Market Share by Application (2018-2029)
Figure 66. Asia Targeted Antitumor Drugs Revenue Market Share by Application (2018-2029)
Figure 67. Asia Targeted Antitumor Drugs Revenue Share by Region (2018-2029)
Figure 68. Asia Targeted Antitumor Drugs Sales Share by Region (2018-2029)
Figure 69. Japan Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. India Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Targeted Antitumor Drugs Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Targeted Antitumor Drugs Sales Share by Country (2018-2029)
Figure 80. Brazil Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Targeted Antitumor Drugs Revenue (2018-2029) & (US$ Million)
Figure 85. Targeted Antitumor Drugs Value Chain
Figure 86. Targeted Antitumor Drugs Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed